Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020)
Open accessThe DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index; 1 of the 8 sources its claims cite were checked for support.
Abstract
The systemic immunity-inflammation index (SII) is a novel inflammatory marker, and aberrant blood lipid levels are linked to inflammation. This study aimed to look at the probable link between SII and hyperlipidemia. The current cross-sectional investigation was carried out among people with complete SII and hyperlipidemia data from the 2015–2020 National Health and Nutrition Examination Survey (NHANES). SII was computed by dividing the platelet count × the neutrophil count/the lymphocyte count. The National Cholesterol Education Program standards were used to define hyperlipidemia. The nonlinear association between SII and hyperlipidemia was described using fitted smoothing curves and threshold effect analyses. A total of 6117 US adults were included in our study. A substantial positive correlation between SII and hyperlipidemia was found [1.03 (1.01, 1.05)] in a multivariate linear regression analysis. Age, sex, body mass index, smoking status, hypertension, and diabetes were not significantly correlated with this positive connection, according to subgroup analysis and interaction testing (p for interaction > 0.05). Additionally, we discovered a non-linear association between SII and hyperlipidemia with an inflection point of 479.15 using a two-segment linear regression model. Our findings suggest a significant association between SII levels and hyperlipidemia. More large-scale prospective studies are needed to investigate the role of SII in hyperlipidemia.
Overview
CoChat Summary
TL;DR
In a cross-sectional NHANES 2015–2020 sample of 6,117 US adults, higher systemic immunity-inflammation index (SII) was associated with higher odds of hyperlipidemia in minimally and partially adjusted models. The association was nonlinear, with an inflection point at SII 479.15, and became statistically insignificant in the fully adjusted model.
Key findings
- Among 6,117 participants, mean SII was 459.54 ± 317.28, mean age was 50.70 ± 17.43 years, 48.08% were male, and 69.72% had hyperlipidemia.
- SII/100 was positively associated with hyperlipidemia in model 1 [OR 1.04 (1.02, 1.06)] and model 2 [OR 1.03 (1.01, 1.05)], but not in fully adjusted model 3 [OR 1.02 (1.00, 1.04)].
- In SII quartile sensitivity analysis using model 2, Quartile 4 was associated with a 27.04% increased risk of hyperlipidemia versus Quartile 1 (p for trend < 0.05).
- A nonlinear association was found with an inflection point of 479.15; in women, an inverted U-shaped curve had an inflection point of 958.14. Subgroup interaction tests were not significant (p for interaction > 0.05).
Methods
- Cross-sectional study using NHANES 2015–2020 data; from 25,531 eligible people, exclusions for missing SII data (5,264), missing hyperlipidemia data (12,969), and age <20 years (1,181) yielded 6,117 participants.
- SII was calculated as platelet count × neutrophil count / lymphocyte count; hyperlipidemia was defined by NCEP ATP III criteria or reported use of cholesterol-lowering drugs.
- Multivariable logistic regression with three adjustment models, smooth curve fitting, threshold effect analysis, and subgroup/interaction testing; analyses used R and EmpowerStats with weighting.
Limitations
- The authors state that the cross-sectional design cannot establish causation and that prospective studies are needed.
- The authors state that residual confounding may remain, including long-term medication use such as steroids, which was not recorded in NHANES; they also note that the inflammation–disease interaction is complex and generalization may be improper.
- Evident from the text: the fully adjusted model 3 did not retain statistical significance, and the abstract describes “multivariate linear regression” while the Methods/Results describe multivariable logistic regression.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
1 Valid · 0 Not valid · 3 Not checked · 21 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This association was significant both in model 1 (1.04 (1.02, 1.06)) and model 2 (1.03 (1.01, 1.05)).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SII was shown to correlate significantly with hyperlipidemia in subgroups stratified by sex, BMI, and diabetes (p < 0.05).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interaction tests revealed that the relationship between SII and hyperlipidemia was not statistically different across strata, showing that age, sex, BMI, smoking status, hypertension, and diabetes did not significantly impact this positive correlation (p for interaction> 0.05).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, in model 3, the positive association between SII and hyperlipidemia became insignificant (1.02 (1.00, 1.04)).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This association was significant both in model 1 (1.04 (1.02, 1.06)) and model 2 (1.03 (1.01, 1.05)).”
- Also stated in: § Abstract · plain
“A substantial positive correlation between SII and hyperlipidemia was found [1.03 (1.01, 1.05)] in a multivariate linear regression analysis.”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plainstates an associationn = 6,117 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
8 more claims
Create a free account to see all 25 claims and to verify the 7 references still open.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 6
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“To minimize the influence of highly variable MHR values, MHR was scaled by multiplying by 10 (19).”
From Retrospective evaluation of novel serum inflammatory biomarkers in first-episode psychiatric disorders: diagnostic potential and immune dysregulation (2024) · doi:10.3389/fpsyt.2024.1442954 · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 2. Materials and Methods > 2.3. SII and Covariates
“The systemic immunity-inflammation index is the dependent variable in this investigation.”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 2. Materials and Methods > 2.3. SII and Covariates
“SII was intended as an exposure variable in our research.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > Abstract
“A substantial positive correlation between SII and hyperlipidemia was found [1.03 (1.01, 1.05)] in a multivariate linear regression analysis.”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 2. Materials and Methods > 2.4. Statistical Analysis
“To examine the association between SII and hyperlipidemia, multivariate logistic regression analysis between SII and hyperlipidemia was used”
Citations
Cites
(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092 · cited 1×
“Adult Treatment Panel III (ATP 3) of the National Cholesterol Education Program (NCEP) classified hyperlipidemia as total cholesterol 200 mg/dL, triglycerides 150 mg/dL, HDL 40 mg/dL in males and 50 mg/dL in females, or low-density lipoprotein 130 mg/dL [21].”
MethodYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987 · cited 1×
“In the United States, 28 million people had total cholesterol levels higher than 240 mg/dL [4].”
BackgroundHeart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797 · cited 1×
“In addition, hyperlipidemia significantly increases the risk of cardiovascular and immune diseases and is a significant cause of stroke and death [5].”
BackgroundTarver, T. (2014) · Journal of Consumer Health On the Internet · doi:10.1080/15398285.2014.902284 · Cited by 5,605
Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0442 · Cited by 2,493
Cancer-related inflammation and treatment effectiveness
Diakos, C. I., Charles, K. A., McMillan, D. C., & Clarke, S. J. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70263-3 · Cited by 2,193
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412 · cited 1×
“described infantile-onset STING-associated vasculopathy caused by a systemic gain-of-function mutation in the TMEM173 gene and in patients characterized by systemic inflammation [37,38].”
BackgroundSelf-citationResolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344 · cited 1×
“The ability of SPM to limit leukocyte infiltration and counter-regulate the production of pro-inflammatory mediators is one of its main biological functions [44].”
BackgroundInflammation and cancer: advances and new agents
Crusz, S. M., & Balkwill, F. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.105 · Cited by 1,184 · cited 1×
“The interaction between systemic inflammation and the local immune response has been identified as the seventh cancer hallmark, and it has been shown to be involved in the initiation, development, and progression of various forms of cancer [11,12].”
Background
Cited by
Items 101–200 of 277
Li, Y., Nie, C., Li, N., Liang, J., Su, N., & Yang, C. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1425956 · Cited by 8
Peng, H., Liang, Z., Huang, B., Zhang, S., & Yang, Y. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1457984 · Cited by 6
Exploring the impact of polychlorinated biphenyls on comorbidity and potential mitigation strategies
Gao, Y., Han, L., Zhou, H., & Tan, J. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1474994 · Cited by 6
Qi, M., Dong, S., Ge, J., Qin, C., Zhang, G., Fu, C., & Sun, S. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.107332 · Cited by 6
“…(Below High School, High School, Above High School) [33], marital status (married/living with partner, widowed/divorced/separated, never married) [34], PIR ( 1.3, 1.3-3.5, ≥3.5) [30], total energy intake [35], hypertension status (Yes or No), BMI ( 25.0, 25.0 to 30.0, ≥30.0) [36], alcohol…”
InfluentialAbudouwayiti, A., Li, Y., Tuerxun, T., Abudurexiti, M., Duan, D., Zheng, Y.-Y., & Mahemuti, A. (2025) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296251328361 · Cited by 8
Octacosanol: Biological activities and bioavailability enhancement strategies
Liang, L., Peng, X. Y., Xiao, Q., Zhong, F., Zeng, X., Li, W., Deng, J., Lin, Q., Luo, F., Cao, Q., et al. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.146891 · Cited by 8
Association between serum Klotho levels and hypothyroidism in older adults: NHANES 2007–2012
Wang, Y., Hu, B., & Yang, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-62297-4 · Cited by 6
Feng, K., Li, P., Guo, H., & Chen, Z. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1434704 · Cited by 6
Association between a body shape index and bone mineral density in US adults based on NHANES data
Wu, J., & Wu, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-86939-3 · Cited by 6
Qian, Y., Xiao, L.-W., Zhang, Y., Li, L., Xia, T., Xu, Q., Xing, S., & Wang, L.-S. (2024) · International Journal of COPD · doi:10.2147/copd.s471068 · Cited by 5
“According to previous studies, 25,26 the calculation of SII is based on an accurate formula: SII = platelet count×neutrophil count/ lymphocyte count, which has high clinical application for evaluating the systemic immune and inflammatory status of individuals.”
MethodGuan, C.-J., Chen, R., & Wang, Y. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2486565 · Cited by 6
Association between systemic immune-inflammation index and chronic bronchitis: NHANES 2001–2018
He, L., Gan, W., Xiao, S., Shi, Y., Fu, M., Wu, L., & Zhang, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-97895-3 · Cited by 5
Huang, J., Zhang, X., Tang, H., Jia, S., Chen, J., Liang, R., Yang, Q., Lin, H., Luo, N., Ren, Y., et al. (2025) · European journal of medical research · doi:10.1186/s40001-025-03131-z · Cited by 5
“…and outlier-driven conclusions caused by acute metabolic abnormalities, we excluded individuals with extremely high or low biochemical values (upper and lower 1% percentiles) and who are known to have diabetes or long-term use of hypoglycemic and lipid-lowering drugs for sensitivity analyses [58].”
Self-citationAssociation between serum neurofilament light chain and periodontitis
Zhao, J. H., & Zhao, P. (2024) · Clinical Oral Investigations · doi:10.1007/s00784-024-05769-1 · Cited by 5
Zeng, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-70648-4 · Cited by 5
“Three different statistical models were employed for determining the relationship between WWI and CircS through the application of multivariable regression analysis.”
MethodZhang, M., Wang, L.-P., Li, X., Wang, L., Li, Y., Yang, S., Song, L., Wan, Z., Lv, Y., Wang, Y., et al. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124987 · Cited by 5
Zhao, M., Zhang, Q., Lin, Y., Zhang, D., & Cao, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310184 · Cited by 6
“Additionally, women who reported the use of cholesterol-lowering medications were also considered to have hyperlipidemia [24, 25].”
BackgroundInfluentialKaraduman, A., Yılmaz, C., Keten, M. F., Balaban, İ., Kültürsay, B., Danışman, N., Tiryaki, M. M., Alızade, E., & Zehir, R. (2024) · Biomarkers in Medicine · doi:10.1080/17520363.2024.2412515 · Cited by 5
de Cedrón, M. G., Moreno‐Rubio, J., Pascual, V. D. L. O., Alvarez, B., Villarino, M., Sereno, M., Gómez-Raposo, C., Roa, S., Gómez, M. L., Merino-Salvador, M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1519978 · Cited by 5
Chen, X., Liao, S., Ouyang, Q.-Y., Wang, P., Huang, G., Zeng, S.-Y., Guo, Q., Li, J., Shen, Y.-X., Li, N., et al. (2025) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-025-08792-9 · Cited by 5
“During OA onset and progression, the immune and inflammatory systems are activated, involving platelets, neutrophils, lymphocytes, and monocytes [19].”
Chen, J., Fang, S., Huo, J., & Yang, N. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02107-y · Cited by 5
“The classification criteria include TC ≥ 200 mg/dL, TG ≥ 150 mg/dL, HDL-C 40 and 50 mg/dL in males and females, or LDL-C ≥ 130 mg/ dL. Additionally, individuals who reported taking cholesterol-lowering drugs were also considered to have hyperlipidaemia [16].”
BackgroundSelf-citationLiu, X., Liu, X., Huang, Y., Lin, C., Chen, X., Li, Y., Huang, Y., & Wang, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1566314 · Cited by 4
Yu, C., Wu, H., Sun, X., Cao, M., & Yuan, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1588965 · Cited by 5
Lyu, H., Xu, S., Li, C., Zeng, C.-L., Zhao, L., & Peng, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-04727-5 · Cited by 4
“Hypertension and hyperlipidemia were determined by a combination of self-reported data, medication use, and clinical measurements or blood test results 19,20 .”
Self-citationSu, Y.-J., Zhang, X., Jiang, J., Zhang, J., & Chen, F. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-05919-8 · Cited by 4
“SII calculated as platelet count×neutrophil count/lymphocyte count, is a novel, cost-effective, and easily accessible biomarker [8].”
Liu, D., He, C., & Luo, X. (2025) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-024-03314-5 · Cited by 6
Han, Y., Liu, C., Nie, Y., Jiang, X., An, N., Qin, Y., Ma, Y., An, Z., & Zhao, Y. (2025) · Scientific Reports · doi:10.1038/s41598-024-85018-3 · Cited by 4
“Participants who self-reported the use of lipid-lowering medications were also grouped under the hyperlipidemia category 24,25 .”
Self-citationWen, C., Liu, X., Lian, Y., Guo, W., Zhang, L., Chen, Y., Lan, X., Li, M., Zhang, S., Huang, W., et al. (2025) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2025.200406 · Cited by 4
“A population-based study based on NHANES found a significant positive correlation of 1.03 (95 %CI, 1.01, 1.05) between systemic immune-inflammatory index SII and dyslipidemia [48].”
InfluentialYang, Q., Li, B., Luan, T., Wang, X., Duan, B., Wei, C., & Chen, S. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1369661 · Cited by 4
Li, T., Li, X., Haoran, X. U., Wang, Y., Ren, J., Jing, S., Jin, Z., Chen, G., Zhai, Y., Wu, Z., et al. (2024) · Computer Methods and Programs in Biomedicine Update · doi:10.1016/j.cmpbup.2024.100164 · Cited by 4
Liao, Y., Zhou, K., Lin, B., Deng, S., Weng, B., & Pan, L. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1517186 · Cited by 4
Du, Y.-Z., Liu, J., Zheng, F.-C., Zhou, Q., & Guo, J. (2025) · European journal of medical research · doi:10.1186/s40001-025-02441-6 · Cited by 4
“Individuals who use cholesterol-lowering medication are also classified under this condition [24].”
Gao, H., Yang, J., Wang, Z., Wu, S., & Yi, Y. (2025) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346251343707 · Cited by 5
Han, Y., Jiao, X., Yang, M., Liu, C., & Zhao, D. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04935-x · Cited by 4
Self-citationXu, Q., Yang, Y., Chen, Y., He, S., Yang, R., Zhu, C., Du, C.-C., Zhang, D., Wang, G., Bian, Y., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120897 · Cited by 4
Association between serum vitamin C and body mass index in adolescents aged 12–19 years
Su, X., Patel, N. D., Chen, J., Chen, Y., Zhou, X., Mo, X., & Zhu, S. (2024) · BMC Public Health · doi:10.1186/s12889-024-19588-2 · Cited by 3
“For the construction of these three models, we refer to several other researchers’ published articles [20– 22] which followed a similar pattern of the analyses.”
ResultSelf-citationMunteanu, S.-N., Huțanu, D., Filip, A.-M., Cozac-Szőke, A. R., Mocan, S. L., & Negovan, A. E. (2024) · Life · doi:10.3390/life14091160 · Cited by 4
“Dyslipidemia was proved to induce and maintain the systemic inflammation present in T2DM patients [12].”
BackgroundXie, P., Wang, D., Zhang, M., Jiang, L., Qiu, Y., Wang, Y., Ye, S., Zhang, M., Tan, L., Chen, S., et al. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01729-1 · Cited by 3
“Individuals who acknowledged using cholesterol-lowering medication were also classified as having hyperlipidemia [35].”
Yang, P., Chen, X. N., Peng, B., Ye, W., Wu, B., Yang, Q., Tang, J., & Yang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-08145-5 · Cited by 3
“Recent studies have also confirmed a significant positive association between the SII and dyslipidemia in the NHANES (2015–2020) population 51 as well as in patients with type 2 diabetic peripheral neuropathy 52 .”
Chen, H., Qiu, M., Zhang, H., Huai, Y., Huang, Q., Li, P., Lei, Y., Jiang, Y., Li, Q., & Zhang, S. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1698455 · Cited by 4
Xu, Z., Luo, X., Diao, W., Tang, X., Zhang, Y., Wang, J., Jiang, Z., & Lei, T. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf369 · Cited by 3
Zhang, J., Yang, C., Dong, X., & An, J. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2599614 · Cited by 3
“Previous studies based on NHANES have confirmed associations between dietary factors, inflammatory indices, obesity, metabolic markers, and hyperlipidemia [7,14–16].”
Qiu, J., Li, J., Xu, S., Fang, L., Zou, Y., Zhou, H., Feng, J., Zan, Y., Lu, Y., Zhou, Y., et al. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03069-w · Cited by 4
Yue, Z., Zhang, Y., Zhang, J., Alimjan, K., Wu, Z., & Shi, L. (2026) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000003157 · Cited by 3
Hu, Y., Huang, Z., Zhao, W., Zhang, H., Li, G., Lin, S., Feng, F., Chen, C., & Liu, Z. (2025) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.24.260 · Cited by 4
“A cross-sectional study including 6,117 adults re-ported that SII was significantly positively correlated with hyperlipidemia, which has been shown to induce inflammatory responses by activating the stimulator of interferon genes pathway [31].”
Gan, H., Yan, Y., Jia, S., Guo, Y., & Lu, G. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112805 · Cited by 3
CALLY Index as a Comprehensive Biomarker for Heart Failure Risk: Findings from NHANES 1999–2010Preprint
Yang, B., Zou, J., Zhou, R., Wang, A., Hu, Y., & Wang, J. (2025) · Research Square · doi:10.21203/rs.3.rs-5909196/v1 · Cited by 3
Jiang, M., Yao, X., Xu, P., & Jiang, H. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s488153 · Cited by 2
“14 In addition, some studies have also demonstrated the high predictive value of the SII in other diseases such as hyperlipidemia 15 and rheumatoid arthritis.”
Xu, Z.-H., Tang, X.-L., Huang, H.-X., Lai, S., Li, H., Liao, D., Du, L., Xiong, Z., Kuang, L., Zhang, B., et al. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.4c11066 · Cited by 2
Impact of atopic dermatitis on renal dysfunction: insights from patient data and animal models
Ikeda, A., Peng, G., Zhao, W., Abudouwanli, A., Ikeda, S., Niyonsaba, F., & Suzuki, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1558596 · Cited by 2
Liu, X.-Y., & Yao, K. (2025) · Mediators of Inflammation · doi:10.1155/mi/1989715 · Cited by 4
“Based on prior studies and clinical signi fi cance, these key variables, which could potentially affect PA and in fl ammatory biomarkers, were included as confounders [10, 21, 43, 46].”
Duan, Y., Zhang, R., Zhang, Y., Ma, Y., Li, M., Zhang, W., & Liu, S. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02042-8 · Cited by 2
“The Systemic Inflammatory Index (SII), derived from the counts of neutrophils, lymphocytes, and platelets in peripheral blood, has recently been used to assess the state of inflammation within the body [10].”
Jiang, M., Liu, Q., Zhang, Y., Shen, Z., & Zhou, W. (2025) · Medicine · doi:10.1097/md.0000000000045335 · Cited by 2
“[11] Recently, studies have suggested that SII is associated with hyperlipidemia, [12] increased urinary albumin excretion, [13] rheumatoid arthritis, [14] hepatic steatosis [15] and hypertension.”
Wang, Y., Sun, Y., Song, J., Fa, D., Qu, Y., Li, J., Fu, X., & Ma, L. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.170537 · Cited by 2
Acosta‐Mérida, M. A., Bañolas‐Suárez, R., Morera‐Sánchez, M., & Marchena‐Gómez, J. (2025) · World Journal of Surgery · doi:10.1002/wjs.70151 · Cited by 3
Chen, Z., Zhu, A., Xu, Z., Qu, Q., Ying, Y., Chen, S., Zhang, H., Cheang, I., & Li, X. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1702364 · Cited by 2
“…were defined as having smoked fewer than 100 cigarettes in their lifetime, former smokers as having smoked more than 100 cigarettes but having quit at the time of the survey, and current smokers as having smoked more than 100 cigarettes and continuing to smoke occasionally or consistently (17).”
Jin, Y., An, H., Zheng, T., Li, J.-J., Gao, J.-M., Zhong, X.-L., Li, B.-H., Liu, Y.-Y., Zhuang, X.-J., Chen, J., et al. (2026) · npj Science of Food · doi:10.1038/s41538-026-00765-z · Cited by 2
Self-citationHuang, S., Wang, Y., Wang, Y., & Miao, Y. (2026) · PLoS ONE · doi:10.1371/journal.pone.0344017 · Cited by 2
“Previous studies have explored systemic inflammation and hyperlipidemia, such as Nayili Mahemuti’s cross-sectional study which showed that SII is associated with a higher risk of hyperlipidemia [18].”
Shen, T., Zheng, Q., Zhong, L., Zeng, X., Yuan, X., Mo, F., Zhu, S., Yang, W., & Chen, Q. (2024) · BMC Public Health · doi:10.1186/s12889-023-17471-0 · Cited by 2
“In addition, people who reported using cholesterol-lowering drugs were and those who had been told they had hyperlipidemia classified as hyperlipidemia [22].”
BackgroundEsin, F. K., Esen, S., Aktürk, S., Pekersen, Ö., Kırış, T., & Karaca, M. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03726-0 · Cited by 2
“There was a significant association between SII levels and hyperlipidemia in National Health and Nutrition Examination Survey (NHANES) adult participants [8].”
BackgroundKim, Y. G., Kim, M. H., Chun, E. M., & Cho, D. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14070671 · Cited by 3
“Additional studies are needed to improve vaccine safety and management strategies for affected individuals.”
BackgroundPark, S., & Keum, D. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14070688 · Cited by 2
Zhang, W., Zhang, C., Lu, D., Nie, J., Hu, Z., Xian, C., & He, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-65925-1 · Cited by 4
“Automated blood analysis equipment was used to measure lymphocyte, neutrophil, and platelet counts, and finally, the SII level was calculated by multiplying the platelet count by the neutrophil count/lymphocyte count 12 .”
InfluentialHao, X., Chen, X., Ren, C., Pan, Y., Xu, Z., Wang, Q., & Liu, X. (2024) · BMC Public Health · doi:10.1186/s12889-024-20880-4 · Cited by 2
“Interaction tests for CDAI with each subgroup were conducted using SPSS to offer more precise risk estimates for the subgroups in the population [24].”
Effect of Dietary Magnesium on the Association Between Serum Uric Acid and Female Infertility
Xin, X., Zhang, Q., Xu, J., & Huang, J. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s484872 · Cited by 2
Zhang, Y., Jia, Y., Sun, C., Zhang, Y., Liao, Y., Liu, H., Zou, R., Niu, L., & Dong, S. (2025) · Journal of Periodontology · doi:10.1002/jper.24-0249 · Cited by 2
Lu, W., Gong, Y., Liu, L., Zhang, Y., Tian, X., & Liu, H. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1502746 · Cited by 2
Relationship between oxidative balance score and risk of sleep-related problems
Chen, P., Wang, J., Liu, L., & Liu, X. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1571971 · Cited by 2
The hidden connection: systemic immune-inflammation index and its role in asthma
Peng, C., Dong, G., Zhou, Z., & Wang, T. (2025) · Clinics · doi:10.1016/j.clinsp.2025.100779 · Cited by 2
Yang, X., Wang, J., Zhang, X., Wu, L., Wang, R., Lu, J., & Wang, L. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15971 · Cited by 2
Chang, C., Yeh, C.-C., Tiong, C., Sun, M.-F., Lin, J.-G., Cherng, Y., Chen, T.-L., & Liao, C. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s466696 · Cited by 1
Bae, S., Kaeding, C. C., Flanigan, D. C., & Barker, T. (2025) · Journal of Orthopaedics · doi:10.1016/j.jor.2025.03.019 · Cited by 1
Association of serum carotenoids and SII among general people, based on NHANES 2001–2006
Yan, S., Nai, W., Peng, L., & Wang, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-94594-x · Cited by 1
“Researches showed that as an important inflammatory marker, the role of SII in various diseases have widely been observed 3,5,25 .”
Ding, Y., Li, J., Gao, C., Xing, L., Sun, R., Guo, Y., Lv, W., Fu, J., Zhao, Y., Li, Q., et al. (2025) · AIDS · doi:10.1097/qad.0000000000004244 · Cited by 1
“Mahemuti [47] identified a significant hyperlipid-emia.”
Yan, Z., Du, X., & Zhang, J. (2025) · Mediators of Inflammation · doi:10.1155/mi/2128440 · Cited by 1
“We included several in fl ammation-related laboratory tests and calculated in fl ammation indicators based on these tests: white blood cell (WBC) count, neutrophil (NEU) count, NEU-to-lymphocyte ratio (NLR) [23], and Systemic Immune-In fl ammation (SII) Index [24].”
Şahiner, Z. (2025) · Ankara City Hospital Medical Journal · doi:10.5505/achmedj.2025.04127 · Cited by 1
Gharab, K. M. K., Bik, M. A., Atta, S. E., Jawad, G. S., Almaghrebi, E., Salman, I. N., & Ünlü, A. (2025) · Qatar medical journal · doi:10.5339/qmj.2025.39 · Cited by 1
Systemic immunity-inflammation index and body mass index: A cross-sectional study
Guo, W., Zhang, C., Cao, F., Sun, X., Li, J., & Zhang, W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327017 · Cited by 1
Long, Q., Liu, Z., Guo, Q., Song, X., & Guo, Y. (2025) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2026.500843 · Cited by 1
Lai, C., Liu, Y. N., Yan, Y., Cheng, B., Liu, Y., Yu, F., Hu, C., Su, L., & Li, F. (2025) · JMIR Public Health and Surveillance · doi:10.2196/76485 · Cited by 1
“…levels are often accompanied by increased concentrations of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and triglyceride-rich lipoprotein cholesterol (TRL-C), as well as decreased concentrations of high-density lipoprotein cholesterol (HDL-C) [14,15].”
Self-citationZhang, F., Lv, J., Aibibula, M., Li, J., Ma, X., He, Y., & Zhou, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1448137 · Cited by 1
“…Education Program classi fi ed hyperlipidemia as total cholesterol 200 mg/dL, triglycerides 150 mg/dL, HDL 40 mg/dL in males and 50 mg/dL in females, or low-density lipoprotein 130 mg/ dL, and persons who reported using cholesterol-lowering drugs were also classi fi ed as having hyperlipidemia (22).”
Liu, W., Lv, Y., Chen, J., Li, X., Huang, Q.-P., Wen, Z., Linghu, X., & Wa, Q. (2025) · Medicine · doi:10.1097/md.0000000000045106 · Cited by 1
“[4] In clinical practice, 2 key inflammatory markers are regularly assessed: C-reactive protein (CRP), a thoroughly validated gauge of systemic inflammation [5] ; Lymphocytes, which serve as essential cellular effectors of immune function.”
Self-citationLiang, Y., & Shi, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-23753-x · Cited by 1
“These observations are consistent with previous studies reporting that higher levels of systemic inflammation, such as the systemic immunity-inflammation index, are associated with increased mortality risk in individuals with hyperlipidemia 9–11 .”
Shen, X., Chen, S., Zeng, M., & Zhang, B. (2025) · Plants · doi:10.3390/plants14223535 · Cited by 1
“Elevated blood lipid levels in patients with hyperlipidemia trigger chronic inflammation, which in turn enhances oxidative stress and aggravates lipid peroxidation [21,22].”
Huang, Y., Huang, Y., Xu, B., Lin, C., Chen, X., Li, Y., Wang, Y., & Liu, X. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01249-8 · Cited by 1
“Hyperlipidemia was deemed present if any of the following criteria were met: use of lipid-lowering medications, hypertriglyceridemia (triglycerides ≥ 150 mg/dL), or hypercholesterolemia (total cholesterol ≥ 200 mg/dL, or LDL ≥ 130 mg/dL, or HDL 40 mg/dL)[25].”
Sui, X., Liu, Y., Zhao, J., Wang, Z., & Zhang, G. (2025) · PLoS ONE · doi:10.1371/journal.pone.0338100 · Cited by 1
Self-citationGou, X., & Chen, Z. (2025) · Medicine · doi:10.1097/md.0000000000046385 · Cited by 1
Mammadova, A., Yalçınkaya, Z., Demirci, N. Y., & Türktaş, H. (2025) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v42i4.17291 · Cited by 1
“Numerous studies have highlighted the strong association between SII and conditions such as hyperlipidemia, heart failure, and mortality due to cardiogenic shock (15-17).”
Huang, H., Dong, D., & Ding, Y. (2025) · BMC Public Health · doi:10.1186/s12889-025-25573-0 · Cited by 1
Huang, J., Song, J., Zhong, M., & Leng, F. (2026) · International Journal of Endocrinology · doi:10.1155/ije/7554085 · Cited by 2
Cheng, H., Qiu, Y., Su, W., & Huang, Z. (2026) · Clinical Rheumatology · doi:10.1007/s10067-025-07755-8 · Cited by 1
“Furthermore, several population-based studies have indicated that elevated SII levels are associated with an increased risk of various chronic diseases [24–26], particularly inflammatory conditions [27].”
Qu, Y., jiang, C., Wang, M., Chen, Y., Liu, Z., Zhang, Z., Li, H., Gui, H., Zhang, Z., & Wang, M. (2026) · Medicine · doi:10.1097/md.0000000000048262 · Cited by 1
Ma, D., Zhou, Q., Yu, J., Xu, C., Yang, L., & Ning, L. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2656098 · Cited by 1
Unveiling promising sepsis biomarkers: a clinical perspective
Zhang, H., Zhao, J., Wang, Z., Huang, M., Tan, Z., Jiang, F., Zhou, Y., Wang, L., & Xiao, M. (2024) · All Life · doi:10.1080/26895293.2024.2369569 · Cited by 2
Association between nocturia and serum albumin in the U.S. adults from NHANES 2005–2012
Jia, Y., Yang, F., Dong, X., Zhou, L., & Long, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308980 · Cited by 1
“…3) of the National Cholesterol Education Program (NCEP) defines hyperlipidemia as having total cholesterol levels � 200 mg/dL, triglycerides � 150 mg/dL, High-density lipoprotein (HDL) levels � 40 mg/dL in men or � 50 mg/dL in women, or Low-density lipoprotein (LDL) levels � 130 mg/dL [18, 19].”
BackgroundIzuora, K. E., Alver, A., Basu, A., Batra, K., Williams, S., & Ebersole, J. L. (2024) · Healthcare · doi:10.3390/healthcare12181804 · Cited by 1
Qing, W., & Qian, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313488 · Cited by 2
“Diagnostic criteria for impaired glucose tolerance (IGT) included an FPG level 7.0 mmol/L and a 2-hour plasma glucose level � 7.8 and 11.1 mmol/L [20] SII and covariates SII, as an exposure variable, was calculated as platelet count × neutrophil count/lymphocyte count [14, 15].”
MethodInfluentialHuang, C., Zhang, Y., Yang, X., Li, G., & Gao, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1502861 · Cited by 1
Association between systemic immune-inflammation index and psoriasis: A cross-sectional studyPreprint
Bo, Y., Zhong, X., Ren, Q., Xiang, Y., Luo, N., Chen, X., Ma, Z., & Hao, P. (2024) · Research Square · doi:10.21203/rs.3.rs-3774560/v1
Polyunsaturated fatty acids associated with delayed biological aging: NHANES 2005–2010Preprint
Jin, S., Zhao, X., & Hu, L. (2024) · Research Square · doi:10.21203/rs.3.rs-4091161/v1
Metadata
- Authors
- Mahemuti, N., Jing, X., Zhang, N., Liu, C., Li, C., Cui, Z., Liu, Y., & Chen, J.
- Affiliations
- Tianjin Medical University (CN)
- Tianjin Huanhu Hospital (CN)
- Corresponding author
- Chen, Jiageng
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-02-26
- Volume
- 15
- Issue
- 5
- Pages
- 1177
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10004774
- OpenAlex
- W4322503120
- Cited by
- 260
- References
- 52
- Citations by year
- 2026: 37 · 2025: 104 · 2024: 105 · 2023: 14
- FWCI
- 32.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Tianjin Health Research Project (TJWJ2022QN062, 2021KJ255)
- Tianjin Municipal Education Commission (TJWJ2022QN062, 2021KJ255)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- hyperlipidemia, inflammation, inflammatory markers, platelet count, neutrophil-to-lymphocyte ratio, nonlinear relationship, threshold effects, serum lipids, adults
- MeSH terms
- Adult, Cross-Sectional Studies, Humans, Hyperlipidemias, Inflammation, Nutrition Surveys, Retrospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.